The fields of artificial intelligence (AI) and machine learning (ML) are increasingly influencing clinical research and development (R&D). Contract research organizations (CROs) and phar… Read More
Blog Directory > Health & Fitness Blogs > Why Choose a Site Network for Your Clinical Trials? health-and-fitness Blog >
Why Choose A Site Network For Your Clinical Trials? Blog
1
Tags:
clinical trials
pros
clinical
clinical
trials
clinical trials
predictive analytics
clinical
clinical trials
For many research sites, navigating the clinical trial landscape can be very intimidating. Gaining credibility, making meaningful connections with sponsors and CROs, and finding new study opportunities can be difficult and time-consuming. Doing these things while also conducting high-quality research can be even more challenging.
The need to choose sites again for each new study is often time-consuming and inefficient. Moreover, the increase in the number of clinical trials and the different exclusion and inclusion criteria across trials have created challenges for selecting sites that perform well. Site network clinical research effectively addresses these concerns and provides cost savings by reducing the total number of sites used and recruiting a large volume of patients.
What Is A Site Network?
A clinical investigative site network is a group of clinical sites represented under one entity and chosen using specific criteria. With a site network, you have access to many sites through one central entity, including one point of contact for all site-related communications and site feasibility assessments over the entire duration of the trial and multiple sites. It allows the team to focus their attention on more critical areas such as patient care and data quality.
Here are reasons why every clinical research site should choose a site network:
Introductions to New Sponsors/CROs:
A vast part of securing study opportunities for your research site is establishing relationships with sponsors and CROs, but establishing these relationships is easier said than done. Another benefit of joining a site network is that site networks already have good relationships with many different sponsors and CROs, which pressures research sites to form these relationships. By taking the pressure of forming relationships with sponsors and CROs off of your research site, you can focus on what is important - your patients and your research.
Streamlined and Accelerated Study Start-Up Process:
Study start-up times are a challenge for sponsors, CROs, and sites alike, but joining a site network can significantly accelerate and streamline this process. Site networks can accelerate the study-start up process in many different ways, including assisting with submission processes, negotiating contracts with sponsors and CROs, and helping with patient recruitment. By improving study start-up times, research sites can build their reputation while still maintaining their patients and research.
Single Point of Contact:
Effective communication between research sites and sponsors, and CROs is crucial for the clinical research process, but this process isn’t always easy. Site networks can benefit from a single point of contact between research sites and the sponsor/CROs, which makes the communication process much simpler for both parties.
Because every organization and study have unique needs, finding a site network that provides the required resources is essential. Plus, understanding these differentiating factors for site networks can help evaluate and select the most appropriate network.
The success of clinical trials hinges on increasing access to participation by all eligible patients, including populations that have been underrepresented due to the barriers highlighted be… Read More
Introduction
Patient-reported outcomes (PROs) refer to information about a patient’s health that is shared directly by the patient and not influenced by the interpretation of any ot… Read More
In the rapidly expanding world of digital health, Medable and Vial CRO (Contract Research Organization), two leading technology organizations, are revolutionizing the way clinical research i… Read More
Introduction
Veeva Systems and Vial CRO (contract research organization) represent stakeholders in the clinical research landscape, which play integral roles in the successful execution o… Read More
Distinguishing the Roles of Preclinical vs. Clinical CROs in Clinical Research
Randomized clinical trials are the gold-standard of evidence-based medicine, representing the culmination of… Read More
Medidata vs. Vial | Pros and Cons
The unprecedented consequences of the COVID-19 pandemic gave rise to the advent of decentralized clinical trials (DCTs), which are studies that use telem… Read More
Amy Del Medico: Hi everyone, I’m Amy del Medico and I’m here today with Josh Mandel-Brehm from CAMP4 Therapeutics. Josh, welcome, would you like to give a little introduction on… Read More
Introduction
The biopharma industry is poised to make revolutionary advances in and redefine drug development, and the current climate for innovation appears ideal. However, progress from… Read More
As technological advancements drive the pharmaceutical industry forward, the shift towards digitalization, particularly with electronic data capture (EDC) systems, has become increasingly pr… Read More
Amy Del Medico: [00:00:00] Hello, everyone. I’m Amy del Medico from Vial. I am here today with Bill Korinek from Astrocyte Pharmaceuticals. Bill, would you like to give us an introduct… Read More
The landscape of medical research is currently in the midst of an exciting transition wherein technology has rapidly become a critical tool for clinical trial management and patient data col… Read More
Introduction
In a landscape where many contract research organizations (CROs) are available, Vial is breaking through with its promise to deliver on its vision to empower scientists to cu… Read More
Amy Del Medico: Hello everyone, I’m Amy Del Medico, VP of Therapeutic Strategy at Vial. I’m here today with Rachel Haynes from Rinri Therapeutics. Rachel, would you like to tell… Read More
The field of ophthalmology is dedicated to preserving and restoring vision, recognizing its significance to human well-being. Yet, hereditary and age-related retinal diseases present challen… Read More
Amy Del Medico: Hello, everybody. I’m Amy del Medico. I’m here today with Bas van der Baan from Lixte. Bas, welcome. Would you like to give a brief introduction?
Bas van der B… Read More
The increasing costs associated with in-house drug development have prompted biotech and pharmaceutical companies to increasingly outsource to contract research organizations (CROs) for assi… Read More
The Costs of Working with a CRO
Running clinical trials is an integral part of the pharmaceutical industry, crucial to the development and approval of new drugs and treatments. However, b… Read More
Amy Del Medico: Hello, I’m Amy del Medico. I’m VP of Ophthalmology here at Vial. I’m here talking today with Samar Mohanty from Nanoscope Therapeutics. Hi Samar, welcome… Read More
Introduction
Worldwide Clinical Trials vs. Vial. How do they stack up? Worldwide Clinical Trials is a mid-size, full-service global contract research organization (CRO) that works with bi… Read More
Rich McCormick: Hi, I’m Rich McCormick, Vice President of Oncology here at Vial. I have the pleasure of being joined by Dr. Neeraj Agarwal. Dr. Agarwal is a Professor of Medicine and a… Read More
Megan Munro: Good morning, Sarah. How are you today? Morning, I’m great. How are you? I’m so good. I’m so excited to ask you five questions.
Sarah Ruiz: Amazing. I… Read More
A contract research organizations (CROs) is a third-party firm contracted by sponsors to deliver specialized services aimed at optimizing their research. The decision to outsource to a CRO i… Read More
Amy Del Medico: Hello, I’m Amy Del Medico and I’m Vice President of Ophthalmology here at Vial. I’m lucky enough to be talking today to Dr. Arshad Khanani and we’re g… Read More
Rich McCormick: Hi, I’m Rich McCormick, executive vice president of CRO operations here at Vial. Today I have the pleasure of welcoming CEO of Clene Inc., Rob Etherington to our First… Read More
Simon Burns: Dr. Tolcher, thank you so much for joining us for a conversation today.
Anthony Tolcher: My pleasure. Nice to meet you again, Simon.
Simon Burns: Let’s jump right in… Read More
The field of clinical research is a dynamic and rapidly evolving one. As such, keeping up to date with the latest trends, advancements, and breakthroughs is a necessity for professionals wit… Read More
Rich McCormick: [00:00:00] Hi, I’m Rich McCormick, Executive Vice President of CRO Operations here at Vial. Today, I have the pleasure of welcoming CEO of CTMC, Dr. Jason Bock to our F… Read More
Introduction
Contract research organizations (CROs) are essential in pharmaceutical research and development (R&D). By geographical region, the global CRO services market in 2023 was… Read More
Contract research organizations (CROs) are an integral partner of the drug development process, as they play a pivotal role supporting clinical trial conduct for pharmaceutical, biotechnolog… Read More
Rich McCormick: [00:00:00] Hi, I’m Rich McCormick, executive vice president of clinical strategy here at Vial. Joining me today on our First In Human podcast is Alex Federation, co-fou… Read More
The pharmaceutical and biotechnological landscape is constantly evolving and a key partner within the drug development process is contract research organizations (CROs), who are at the foref… Read More
In 2022, the global market value of patient portals within the clinical research and healthcare industries was estimated to be US $2.9 billion and is expected to climb at a compound annual g… Read More
Rich McCormick: Hi, I’m Rich McCormick, Vice President of Oncology here at Vial. Joining me is Dr. Brian Rini, Chief of Clinical Trials at Vanderbilt Ingram Cancer Center. Today we&rsq… Read More
Medical devices have seen a significant increase in market demand for the past few years. There is a strong demand for innovative products that are essential in monitoring, preventing, and t… Read More
Join Dr. Ahmed Hamdy, CEO of Vincerx Pharma, on a compelling journey through oncology. From co-founding Acerta Pharma to pioneering patient-centric innovations, Dr. Hamdy shares his impactfu… Read More
Clinical trials play a crucial role in advancing medical breakthroughs, but effective management is essential to unlock their full potential.
Pharmaceutical companies often face challenge… Read More
Have you ever considered the untapped potential of abandoned drugs? Join Dr. Sam Clark to discuss how his personal drive to combat mental illness is leading to breakthroughs in treatments fo… Read More
To advance new therapies, pharmaceutical, biotech, and medical device companies engage contract research organizations (CROs) for their know-how in navigating the complex landscape of drug d… Read More
Dive into the world of software engineering with Chris Tam in our latest segment, “5 Questions on Unlocking the Power of Software Engineering Principles.” Join Chris as he shares… Read More
Ever wondered how technology could drastically improve early detection in healthcare? Let us take you on a journey with Mark McDonough, President and CEO of ChromaCode, as we unfold the worl… Read More
Embark on a journey through the intricate world of biotech with Bogdan Kezevic, co-founder and CEO of Kaleidoscope Bio, and uncover the revolutionary software shaping the future of scientifi… Read More
What does it take to revolutionize the world of vaccines and touch lives across the globe? Join us on a riveting journey with Steven Reed, CEO and co-founder of HDT-Bio, as we explore the cr… Read More
Catch up with Brennan, a seasoned product designer at Vial. In this insightful interview, Brennan shares invaluable insights into his journey shaping product design at Vial, leveraging a uni… Read More
Artificial intelligence (AI) has been an emerging area in clinical research. One of the biggest bottlenecks in discovering new therapeutics is lead generation and preclinical testing. AI has… Read More
Key Takeaways
Battery Bio is advancing 6 antibody programs developed using Protein Language Models
The 6 antibody programs are targeting unmet needs in Immunology: Atopic Dermatitis, H… Read More
Join Jeffrey Bacha, a pioneer in the fight against cancer and the creative force behind Rakovina Therapeutics. For 25 years, Jeffrey has been reshaping the industry landscape, and today, he… Read More
Within the biotechnology industry, small biotech startups often find themselves competing against industry giants. These larger organizations, backed by vast resources and a deep-rooted mark… Read More
Clinical sites have endured a particularly challenging period in recent years, from adopting new operating models and technologies supporting decentralized clinical trials (DCTs) to mitigati… Read More
Gastrointestinal (GI) clinical research has evolved over time. In this article, we explore the latest trends and innovations, including the use of big data and artificial intelligence (AI)… Read More
Starting up a new site can be a challenging and time-consuming process, often filled with unforeseen hurdles and delays. According to a study by the Tufts Center for the Study of Drug Develo… Read More
Embark on a fascinating exploration of biotech entrepreneurship, guided by an expert who’s been in the trenches: Jonathan Thon, CEO and founder of STRM.BIO. We’ll give you an ins… Read More
Hepatitis C virus (HCV) infection is a global health problem with complications that place a significant economic burden on national health systems. Pathophysiological evidence links HCV inf… Read More
Ophthalmology is a constantly evolving therapeutic area. With technological innovation and scientific research propelling the development of new therapies, anticipation for the future is hig… Read More
Join Dr. Siegfried Kasper, Professor of Psychiatry at the Medical University of Vienna, Dr. Nicola Specchio, Head of Epilepsy at Bambino Gesù Children’s Hospital, and Emma… Read More
In the ever-evolving field of medical science, artificial intelligence (AI) has emerged as a revolutionary tool, particularly in drug discovery. As a newer alternative to the time-consuming… Read More
Join Connor McDiarmid as he answers five questions delving into the transformative role of AI in drug development, and outlines key advancements shaping the industry for increased efficiency… Read More
The Inflation Reduction Act (IRA) is a vital piece of legislation brought into effect by President Biden in 2022. The Act is primarily designed to create an inclusive economy that caters to… Read More
Next-generation sequencing (NGS) has revolutionized scientific research and clinical genomics due to high-throughput multiplexing and shed light on genome structure, function, and dynamics… Read More
Ever wondered how far we’ve truly come in the realm of gene and cell therapies, and where we’re headed next? This captivating conversation with Oscar Segurado, the CMO of ACS The… Read More
Clinical research is an integral component of the healthcare ecosystem. It is pivotal in the development of cutting-edge treatments, therapies, and interventions for a wide array of diseases… Read More
Clinical trials play a crucial role in the development and evaluation of new medical treatments and interventions, providing valuable insights into the safety and efficacy of drugs, medical… Read More
Immune evasion, a recognized hallmark of cancer, has been a central focus in oncology research for developing novel therapeutics. The field of immuno-oncology has emerged as a specialized br… Read More
As the pharmaceutical and drug discovery field undergoes transformation fueled by technological advancements and evolving regulatory demands, research institutions find themselves grappling… Read More
In today’s highly competitive business landscape, pharmaceutical and biotech companies constantly seek ways to optimize their operations and reduce costs. Outsourcing clinical research… Read More
We’re thrilled to share our enlightening exchange with Spiro Rombotis, the seasoned CEO of Cyclacel. He peels back the curtain on the breakthrough discovery of B53, a commonly mutated… Read More
Oncology clinical trials are at the forefront of cancer research and Biotechnology, representing a beacon of hope for patients seeking innovative treatments. However, these trials are comple… Read More
Automated laboratories (automated labs), facilities equipped with advanced systems and technologies that streamline and optimize various laboratory processes, have made a significant impact… Read More
The early discovery of HER2, its established oncogenic relevance in various cancers, and its druggability have made it one of the most pursued targets in cancer drug development. The develop… Read More
Biotechnology, often referred to as “biotech,” is a dynamic and rapidly evolving field that has revolutionized various aspects of our lives. From healthcare and agriculture to in… Read More
Immunomodulators act to regulate a patient’s immune system, helping it perform more effectively by increasing or suppressing its immune response. Age-related macular degeneration (AMD)… Read More
In parallel with the discoveries and advancements brought about by clinical research, clinical trial design, conduct, and analysis will continue to evolve and advance in 2024. Biotech and Bi… Read More
The pharmaceutical industry is in the midst of a significant transformation, as machine learning (ML) begins to play a larger role in the drug design process. As artificial intelligence (AI)… Read More
San Francisco, CA. November 14, 2023 — Vial, a global tech-driven contract research organization (CRO) providing next-generation clinical trial management services, has announced its s… Read More
In clinical research, precision, accuracy, and integrity are paramount. Every data point collected and every outcome measured can have far-reaching consequences, not only for patients but al… Read More
Cancer is an immensely complex disease that involves the aberrant growth and proliferation of cells. Despite significant advancements in cancer research and therapy, it remains one of the le… Read More
Designing new drugs can be a tedious and laborious process. The result has been that relatively few effective new drugs have been clinically implemented in the past several decades. Utilizin… Read More
The clinical research industry is constantly evolving, and as a result, the need for a world-class clinical organization to optimize operational excellence has become more paramount than eve… Read More
In the last decades, we have witnessed remarkable progress in scientific research, with advancements in understanding disease processes, cellular mechanisms, and the development of transform… Read More
Adeno-associated viruses (AAV) are replication-defective, non-pathogenic, single-stranded viruses that have become one of the leading gene delivery vectors in clinical trials. Researchers es… Read More
Randomization and Trial Supply Management (RTSM), at times used interchangeably with Interactive Response Technology (IRT), is more accurately an evolution of traditional IRT as it reflects… Read More
The U.S. Food and Drug Administration (FDA) is a federal agency that protects and promotes public health by ensuring the safety, efficacy, and security of a wide range of products that are c… Read More
In this insightful interview, Enejo, a seasoned data manager, shares valuable strategies and protocols for ensuring the quality, security, and integrity of clinical trial data, emphasizing p… Read More
Artificial intelligence (AI) and machine learning (ML) have emerged as powerful tools revolutionizing various industries, and the field of drug discovery is no exception. Between 2020 and 20… Read More
Translational biology is the scientific process that bridges observations made in biological sciences with practical interventions that directly benefit human health and well-being. Translat… Read More
Cancer is a global health issue that poses a significant burden on individuals, families, and society as a whole. In the United States alone, nearly 2 million new cases of cancer and over 60… Read More
LatchBio, a San Francisco-based biotechnology company, is making significant strides in revolutionizing the field of clinical research by helping clinical researchers overcome data storage l… Read More
Personalized medicine uses an individual’s genetic profile to tailor prevention, diagnosis, and therapies. It aims to optimize healthcare for individuals by using predictive biomarkers… Read More
The Food and Drug Administration (FDA) requires that all medical devices undergo multiple phases of testing before they are introduced for human use. To secure approval, extensive research a… Read More
Companion diagnostics (CDx) provides information essential for the safe and effective use of a corresponding intervention. Clinical practice is shifting to the era of precision medicine, and… Read More
Ever wondered about the people who are leading the fight against cancer, developing groundbreaking treatments, and changing lives? Meet Frank Boriello, the mind behind SUPLEXA cell therapy… Read More
In the field of laboratory science, automation has revolutionized the way experiments and research are conducted. An automated lab refers to a facility equipped with advanced systems and tec… Read More
Radiopharmaceuticals are an emerging and promising approach for diagnosing and treating various types of cancer. Radiopharmaceutical therapy (RPT) has demonstrated effectiveness with minimal… Read More
HIV (human immunodeficiency virus) is a devastating global health crisis that has affected millions of individuals worldwide; in 2022 alone, nearly 39 million individuals were living with th… Read More
ProteinQure, a prominent player in the biotech industry, has revolutionized the development of peptide therapeutics through their state-of-the-art platform, ProteinStudio. This innovative te… Read More
Clinical trials serve as the backbone of drug development, ensuring the safety and efficacy of new medications before they are made available to the general public. Drug safety, the study of… Read More
Max Darnell, CEO and co-founder of Modulus Therapeutics, takes us through his thrilling journey from bioengineering and systems biology to launching a biotech startup. Max unveils how his te… Read More
Clinical research is a vital aspect of healthcare that aims to study the safety and efficacy of medical interventions using various types of clinical trials, which are conducted in different… Read More
Obesity clinical trials experience significant challenges in recruitment and retention, facing high attrition rates coupled with low trial success rates. Obesity clinical research on weight… Read More
With the rising incidence of cancer and neurological disorders, many of which have historically been considered untreatable, gene therapy and technological advances are working to rapidly ch… Read More